AbbVie vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?
Key PointsAbbVie is aggressively diversifying its pipeline to mitigate the revenue impact from its loss of patent exclusivity on Humira.
Key PointsAbbVie is aggressively diversifying its pipeline to mitigate the revenue impact from its loss of patent exclusivity on Humira.